<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31224" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Vitamin D Deficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sizar</surname>
            <given-names>Omeed</given-names>
          </name>
          <aff>St. Lucie Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Khare</surname>
            <given-names>Swapnil</given-names>
          </name>
          <aff>Indiana University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Givler</surname>
            <given-names>Amy</given-names>
          </name>
          <aff>Ochsner/LSU Health Monroe</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Omeed Sizar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Swapnil Khare declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amy Givler declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>17</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31224.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Vitamin D is a fat-soluble vitamin used by the body for normal bone development and maintenance by increasing the absorption of calcium, magnesium, and phosphate. A circulating level of 25-hydroxyvitamin D greater than 30 ng/mL is required to maintain a healthy level of vitamin D. Vitamin D deficiency can lead to an array of problems, most notably rickets in children and osteoporosis in adults. The fortification of milk with vitamin D in the 1930s was effective in eradicating rickets in the world. However, vitamin D deficiency is more prevalent than ever, and high-risk populations should be screened. Many conflicting studies are now showing an association between vitamin D deficiency and cancer, cardiovascular disease, diabetes, autoimmune diseases, and depression. This activity reviews the evaluation and management of vitamin D deficiency and explains the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the etiology of vitamin D deficiency.</p></list-item><list-item><p>Discuss the pathophysiology and epidemiology of vitamin D deficiency.</p></list-item><list-item><p>Review evaluation and management of vitamin D deficiency.</p></list-item><list-item><p>Outline the role of the interprofessional team in evaluating and managing patients with vitamin D deficiency.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31224&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31224">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31224.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Vitamin D is a fat-soluble vitamin that plays an important role in calcium homeostasis and bone metabolism. Vitamin D deficiency can lead to osteomalacia and rickets in children and osteomalacia in adults.&#x000a0;The fortification of milk with vitamin D in the 1930s was effective in eradicating rickets in the world. However, subclinical vitamin D deficiency is still widely prevalent in both developed and developing countries, with a worldwide prevalence of up to 1 billion.<xref ref-type="bibr" rid="article-31224.r1">[1]</xref>&#x000a0; This subclinical vitamin-D deficiency is associated with osteoporosis, increased risk of falls, and fragility fractures.&#x000a0;Many conflicting recent studies are now showing an association between vitamin D deficiency and cancer, cardiovascular disease, diabetes, autoimmune diseases, and depression.<xref ref-type="bibr" rid="article-31224.r2">[2]</xref></p>
      </sec>
      <sec id="article-31224.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Dermal synthesis and dietary intake (fatty fish livers, fortified food) are the major sources of ergocalciferol (D2) and cholecalciferol (D3), both of which are converted to 25-hydroxy-vitamin D2 (25-OH-D2) and&#x000a0;25-hydroxy-vitamin D3 (25-OH-D3) respectively in the liver by the enzyme&#x000a0;hepatic enzyme 25&#x02013;hydroxylase. 25-OH-D2 and 25-OH-D3 are then converted to the most active form of vitamin D (1,25 dihydroxyvitamin D) by the enzyme&#x000a0;1-alpha-hydroxylase in the kidneys. This active&#x000a0;1,25 dihydroxyvitamin D&#x000a0;increases intestinal absorption of calcium and bone resorption and decreases renal excretion of calcium and phosphate.&#x000a0;Vitamin D deficiency can result from several causes.</p>
        <p>
<bold>1. Decreased dietary intake and/or absorption</bold>
</p>
        <p>Certain malabsorption syndromes such as celiac disease, short bowel syndrome, gastric bypass, inflammatory bowel disease, chronic pancreatic insufficiency, and cystic fibrosis may lead to vitamin D deficiency. Lower vitamin D intake orally is more prevalent in the elderly&#x000a0;population.&#x000a0;<xref ref-type="bibr" rid="article-31224.r3">[3]</xref></p>
        <p>
<bold>2. Decreased sun exposure</bold>
</p>
        <p>Twenty minutes of sunshine daily with over 40% of skin exposed is required to prevent vitamin D deficiency.<xref ref-type="bibr" rid="article-31224.r4">[4]</xref>&#x000a0;Cutaneous synthesis of vitamin D declines with aging. Dark-skinned people have less cutaneous vitamin D synthesis. Decreased exposure to the sun, as seen in individuals who are institutionalized or have prolonged hospitalizations, can also lead to vitamin D deficiency.&#x000a0;<xref ref-type="bibr" rid="article-31224.r5">[5]</xref>&#x000a0;Effective sun exposure is decreased in individuals who use sunscreens consistently.&#x000a0;</p>
        <p>
<bold>3. Decreased endogenous synthesis</bold>
</p>
        <p>Individuals with chronic liver disease such as cirrhosis can have defective 25-hydroxylation, leading to deficiency of active vitamin D. Defects in 1-alpha 25-hydroxylation can be seen in hyperparathyroidism, renal failure, and 1-alpha hydroxylase deficiency.&#x000a0;</p>
        <p>
<bold>4. Increased hepatic catabolism</bold>
</p>
        <p>Medications such as phenobarbital, carbamazepine, dexamethasone, nifedipine, spironolactone, clotrimazole, and rifampin induce hepatic p450 enzymes, which activate the degradation of vitamin D.<xref ref-type="bibr" rid="article-31224.r6">[6]</xref></p>
        <p>
<bold>5. End organ resistance</bold>
</p>
        <p>End-organ resistance to vitamin D can be seen in hereditary vitamin D-resistant rickets.</p>
      </sec>
      <sec id="article-31224.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Vitamin D deficiency is a global public health issue.&#x000a0;About 1 billion people worldwide have vitamin D deficiency, while 50% of the population has vitamin D insufficiency.<xref ref-type="bibr" rid="article-31224.r1">[1]</xref>&#x000a0;The prevalence of patients with vitamin D deficiency is highest in the elderly, obese patients, nursing home residents, and hospitalized patients. The prevalence of vitamin D deficiency was 35% higher in obese subjects irrespective of latitude and age.<xref ref-type="bibr" rid="article-31224.r7">[7]</xref>&#x000a0;In the United States, about&#x000a0;50% to 60% of nursing home residents and hospitalized patients had vitamin D deficiency.&#x000a0;<xref ref-type="bibr" rid="article-31224.r8">[8]</xref><xref ref-type="bibr" rid="article-31224.r9">[9]</xref>&#x000a0;Vitamin&#x000a0;D deficiency may&#x000a0;be related to populations who have higher skin melanin content and who use extensive skin coverage, particularly in Middle Eastern countries. In the United States, 47% of African American infants and 56% of Caucasian infants have vitamin D deficiency, while over 90% of infants in Iran, Turkey, and India have vitamin D deficiency. In the adult population, 35% of adults in the United States are vitamin D deficient whereas&#x000a0;over 80% of adults in Pakistan, India, and Bangladesh are Vitamin D deficient. In the United States, 61% of the elderly population is vitamin D deficient whereas 90% in Turkey, 96% in India, 72% in Pakistan, and 67% in Iran were vitamin D deficient.<xref ref-type="bibr" rid="article-31224.r10">[10]</xref></p>
      </sec>
      <sec id="article-31224.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Vitamin D plays a crucial role in calcium homeostasis and bone metabolism. With chronic and/or severe vitamin D deficiency, a decline in intestinal calcium and phosphorus absorption leads to hypocalcemia, leading to secondary hyperparathyroidism. This secondary hyperparathyroidism then leads to phosphaturia and accelerated bone demineralization. This can further result in osteomalacia and osteoporosis in adults and osteomalacia and rickets in children.</p>
      </sec>
      <sec id="article-31224.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The majority of patients with vitamin D deficiency are asymptomatic. However, even mild chronic vitamin D deficiency can lead to chronic hypocalcemia and hyperparathyroidism, which can contribute risk of osteoporosis, falls, and fractures, especially in older individuals.&#x000a0;Patients with prolonged and severe vitamin D deficiency can experience symptoms associated with secondary hyperparathyroidism, including bone pain, arthralgias, myalgias, fatigue, muscle twitching (fasciculations), and weakness.&#x000a0;Fragility fractures may result from chronic vitamin D deficiency, leading to osteoporosis.&#x000a0;In children, irritability, lethargy, developmental delay, bone changes, or fractures can be symptoms of vitamin D deficiency.</p>
      </sec>
      <sec id="article-31224.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>High-risk individuals shall be evaluated for vitamin D deficiency. Vitamin D sufficiency or deficiency is evaluated by the measurement of serum 25-hydroxyvitamin D. Optimal serum levels of 25-hydroxyvitamin D are still controversial. There are substantial differences in mineral metabolism amongst different races. African Americans, for example, have higher bone density and low fracture risk compared to other races. Further, the effects of calcium and vitamin D supplementation in the non-White population have not yet been completely evaluated or reported. The International Society for Clinical Densitometry and the International Osteoporosis Foundation recommend minimum serum levels of 25-hydroxyvitamin D of 30 ng/mL to minimize the risk of falls and fractures in older individuals.&#x000a0;<xref ref-type="bibr" rid="article-31224.r11">[11]</xref> There is insufficient data about the maximum safe upper level of serum&#x000a0;25-hydroxyvitamin D; however, at high levels such as above 100 ng/mL, there is a potential risk of toxicity due to secondary hypercalcemia. In patients where vitamin-D deficiency has been diagnosed, it is important to evaluate for secondary hyperparathyroidism, and levels of parathyroid hormone and serum calcium shall be checked.</p>
      </sec>
      <sec id="article-31224.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Several preparations of vitamin D are available.&#x000a0;Vitamin D3 (cholecalciferol), compared with vitamin D2 (ergocalciferol),&#x000a0;has been shown to be more efficacious in achieving optimal 25-hydroxyvitamin D levels,&#x000a0;thus favoring vitamin D3 as a treatment of choice.&#x000a0;<xref ref-type="bibr" rid="article-31224.r12">[12]</xref></p>
        <p>
<bold>Prevention of Vitamin D Deficiency</bold>
</p>
        <p>Adults less than 65 years of age who do not have year-round effective sun exposure shall&#x000a0;consume 600 to 800 international units of vitamin D3 daily to prevent deficiency. Older adults 65 years of age or more shall consume 800 to 1000 international units of vitamin D3 daily to prevent deficiency and reduce the risk of fractures and falls.</p>
        <p>
<bold>Management of Vitamin D Deficiency</bold>
</p>
        <p>The amount of vitamin D required to treat the deficiency depends largely on the degree of the deficiency and underlying risk factors.</p>
        <list list-type="bullet">
          <list-item>
            <p>Initial supplementation for 8 weeks with Vitamin D3, either 6,000 IU daily or 50,000 IU weekly, can be considered.<xref ref-type="bibr" rid="article-31224.r13">[13]</xref>&#x000a0;Once the serum 25-hydroxyvitamin D level exceeds 30 ng/mL, a&#x000a0;daily maintenance dose of 1,000 to 2,000 IU is recommended.</p>
          </list-item>
          <list-item>
            <p>A higher-dose initial supplementation with vitamin D3 at 10,000 IU daily may be needed in high-risk adults who are vitamin D deficient (African Americans, Hispanics, obese, taking certain medications, malabsorption syndrome). Once serum 25-hydroxyvitamin&#x000a0;D level exceeds 30ng/mL, 3000 to 6000 IU/day maintenance dose is recommended.</p>
          </list-item>
          <list-item>
            <p>Children&#x000a0;who are vitamin&#x000a0;D deficient require 2000 IU/day of vitamin D3 or 50,000 IU of vitamin D3 once weekly for 6 weeks. Once the serum 25(OH)D level exceeds 30 ng/mL, 1000 IU/day maintenance treatment is recommended. According to the American Academy of Pediatrics, breastfed infants and children who consume less than 1 L of vitamin D-fortified milk need 400 IU of vitamin D supplementation.</p>
          </list-item>
          <list-item>
            <p>Calcitriol can be considered where the deficiency persists despite treatment with vitamin D2 and/or D3. The serum calcium level shall be closely monitored in these individuals due to an increased risk of hypercalcemia secondary to calcitriol.</p>
          </list-item>
          <list-item>
            <p>Calcidiol can be considered in patients with fat malabsorption or severe liver disease.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31224.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Celiac sprue</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Cystic fibrosis</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>End-stage liver disease</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Inadequate sunlight exposure</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Lack of dietary intake</p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p>Use of antiepileptic medications</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31224.s10" sec-type="Pertinent Studies and Ongoing Trials">
        <title>Pertinent Studies and Ongoing Trials</title>
        <p>A meta-analysis of 18 randomized controlled trials (RCT) including over 57,000 subjects found that intake of daily doses of vitamin D supplements decreased total mortality rates.<xref ref-type="bibr" rid="article-31224.r14">[14]</xref>&#x000a0;In the Women&#x02019;s Health Initiative, calcium and vitamin D supplementation decreased the risk of total cancer, breast cancer, and colorectal cancer while not changing total mortality.<xref ref-type="bibr" rid="article-31224.r15">[15]</xref>&#x000a0;One RCT showed that calcium plus vitamin D substantially reduced all cancer risk in postmenopausal women.<xref ref-type="bibr" rid="article-31224.r16">[16]</xref>&#x000a0;In a meta-analysis study from three randomized controlled trials, vitamin D supplementation was found to reduce the rate of COPD exacerbations in patients with vitamin D levels below 25 nmol/L.<xref ref-type="bibr" rid="article-31224.r17">[17]</xref></p>
      </sec>
      <sec id="article-31224.s11" sec-type="Toxicity and Adverse Effect Management">
        <title>Toxicity and Adverse Effect Management</title>
        <p>Vitamin D is a fat-soluble vitamin; hence, toxicity is possible, although rarely noted. Hypervitaminosis D results from excess oral intake and not due to excessive sunlight exposure. Toxicity has been reported at a serum 25-hydroxyvitamin D level of more than&#x000a0;88 ng/mL. Acute intoxication can lead to acute hypercalcemia that can cause&#x000a0;confusion, anorexia, vomiting, polyuria, polydipsia, and muscle weakness. Chronic intoxication can lead to nephrocalcinosis and bone pain.</p>
      </sec>
      <sec id="article-31224.s12" sec-type="Staging">
        <title>Staging</title>
        <p>The severity of vitamin D deficiency is divided into mild, moderate, and severe.<xref ref-type="bibr" rid="article-31224.r18">[18]</xref></p>
        <p>Mild deficiency:&#x000a0;25-hydroxyvitamin D less than 20 ng/mL</p>
        <p>Moderate deficiency:&#x000a0;25-hydroxyvitamin D less than 10 ng/mL</p>
        <p>Severe deficiency:&#x000a0;25-hydroxyvitamin D less than 5 ng/mL</p>
      </sec>
      <sec id="article-31224.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Vitamin D deficiency is often overlooked in outpatient and inpatient settings. According to the U.S. Preventive Services Task Force (USPSTF), universal screening for vitamin D levels is not recommended; however, it is important to note that&#x000a0;screening for vitamin D deficiency in asymptomatic high-risk individuals is paramount in preventing future complications. High-risk populations include nursing home residents, elderly patients, women with osteoporosis, African American/Hispanic individuals, hospitalized patients, patients with chronic kidney disease, chronic liver disease, and patients with malabsorption syndromes.<xref ref-type="bibr" rid="article-31224.r9">[9]</xref></p>
      </sec>
      <sec id="article-31224.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31224&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31224">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/nutrition/vitamin-d-deficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31224">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31224/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31224">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-31224.s15">
        <title>References</title>
        <ref id="article-31224.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nair</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Maseeh</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D: The "sunshine" vitamin.</article-title>
            <source>J Pharmacol Pharmacother</source>
            <year>2012</year>
            <month>Apr</month>
            <volume>3</volume>
            <issue>2</issue>
            <fpage>118</fpage>
            <page-range>118-26</page-range>
            <pub-id pub-id-type="pmid">22629085</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holick</surname>
                <given-names>MF</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D: important for prevention of osteoporosis, cardiovascular heart disease, type 1 diabetes, autoimmune diseases, and some cancers.</article-title>
            <source>South Med J</source>
            <year>2005</year>
            <month>Oct</month>
            <volume>98</volume>
            <issue>10</issue>
            <fpage>1024</fpage>
            <page-range>1024-7</page-range>
            <pub-id pub-id-type="pmid">16295817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Czernichow</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Nocea</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Sen</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>Calcium and vitamin D intake by postmenopausal women with osteoporosis in France.</article-title>
            <source>Curr Med Res Opin</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>26</volume>
            <issue>7</issue>
            <fpage>1667</fpage>
            <page-range>1667-74</page-range>
            <pub-id pub-id-type="pmid">20446889</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Naeem</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Vitamin d deficiency- an ignored epidemic.</article-title>
            <source>Int J Health Sci (Qassim)</source>
            <year>2010</year>
            <month>Jan</month>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>V</fpage>
            <page-range>V-VI</page-range>
            <pub-id pub-id-type="pmid">21475519</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thomas</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lloyd-Jones</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Thadhani</surname>
                <given-names>RI</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Deraska</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Kitch</surname>
                <given-names>BT</given-names>
              </name>
              <name>
                <surname>Vamvakas</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Prince</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Finkelstein</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Hypovitaminosis D in medical inpatients.</article-title>
            <source>N Engl J Med</source>
            <year>1998</year>
            <month>Mar</month>
            <day>19</day>
            <volume>338</volume>
            <issue>12</issue>
            <fpage>777</fpage>
            <page-range>777-83</page-range>
            <pub-id pub-id-type="pmid">9504937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gr&#x000f6;ber</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Kisters</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Influence of drugs on vitamin D and calcium metabolism.</article-title>
            <source>Dermatoendocrinol</source>
            <year>2012</year>
            <month>Apr</month>
            <day>01</day>
            <volume>4</volume>
            <issue>2</issue>
            <fpage>158</fpage>
            <page-range>158-66</page-range>
            <pub-id pub-id-type="pmid">22928072</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pereira-Santos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Assis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>DB</given-names>
              </name>
            </person-group>
            <article-title>Obesity and vitamin D deficiency: a systematic review and meta-analysis.</article-title>
            <source>Obes Rev</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>16</volume>
            <issue>4</issue>
            <fpage>341</fpage>
            <page-range>341-9</page-range>
            <pub-id pub-id-type="pmid">25688659</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elliott</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Binkley</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Carnes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>DR</given-names>
              </name>
              <name>
                <surname>Petersen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Behlke</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Ahmann</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kieser</surname>
                <given-names>MA</given-names>
              </name>
            </person-group>
            <article-title>Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D.</article-title>
            <source>Pharmacotherapy</source>
            <year>2003</year>
            <month>Jun</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>702</fpage>
            <page-range>702-10</page-range>
            <pub-id pub-id-type="pmid">12820811</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kennel</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Drake</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Hurley</surname>
                <given-names>DL</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D deficiency in adults: when to test and how to treat.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>85</volume>
            <issue>8</issue>
            <fpage>752</fpage>
            <page-range>752-7; quiz 757-8</page-range>
            <pub-id pub-id-type="pmid">20675513</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palacios</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Gonzalez</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Is vitamin D deficiency a major global public health problem?</article-title>
            <source>J Steroid Biochem Mol Biol</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>144 Pt A</volume>
            <fpage>138</fpage>
            <page-range>138-45</page-range>
            <pub-id pub-id-type="pmid">24239505</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dawson-Hughes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Mithal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bonjour</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Boonen</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Burckhardt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fuleihan</surname>
                <given-names>GE</given-names>
              </name>
              <name>
                <surname>Josse</surname>
                <given-names>RG</given-names>
              </name>
              <name>
                <surname>Lips</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Morales-Torres</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yoshimura</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>IOF position statement: vitamin D recommendations for older adults.</article-title>
            <source>Osteoporos Int</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>21</volume>
            <issue>7</issue>
            <fpage>1151</fpage>
            <page-range>1151-4</page-range>
            <pub-id pub-id-type="pmid">20422154</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tripkovic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Hart</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Bucca</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Penson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chope</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hypp&#x000f6;nen</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Berry</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vieth</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lanham-New</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2012</year>
            <month>Jun</month>
            <volume>95</volume>
            <issue>6</issue>
            <fpage>1357</fpage>
            <page-range>1357-64</page-range>
            <pub-id pub-id-type="pmid">22552031</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holick</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Binkley</surname>
                <given-names>NC</given-names>
              </name>
              <name>
                <surname>Bischoff-Ferrari</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Gordon</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Hanley</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Heaney</surname>
                <given-names>RP</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>CM</given-names>
              </name>
              <collab>Endocrine Society</collab>
            </person-group>
            <article-title>Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline.</article-title>
            <source>J Clin Endocrinol Metab</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>96</volume>
            <issue>7</issue>
            <fpage>1911</fpage>
            <page-range>1911-30</page-range>
            <pub-id pub-id-type="pmid">21646368</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Autier</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gandini</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.</article-title>
            <source>Arch Intern Med</source>
            <year>2007</year>
            <month>Sep</month>
            <day>10</day>
            <volume>167</volume>
            <issue>16</issue>
            <fpage>1730</fpage>
            <page-range>1730-7</page-range>
            <pub-id pub-id-type="pmid">17846391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bolland</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Grey</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gamble</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Reid</surname>
                <given-names>IR</given-names>
              </name>
            </person-group>
            <article-title>Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2011</year>
            <month>Oct</month>
            <volume>94</volume>
            <issue>4</issue>
            <fpage>1144</fpage>
            <page-range>1144-9</page-range>
            <pub-id pub-id-type="pmid">21880848</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lappe</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Travers-Gustafson</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Davies</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Recker</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Heaney</surname>
                <given-names>RP</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial.</article-title>
            <source>Am J Clin Nutr</source>
            <year>2007</year>
            <month>Jun</month>
            <volume>85</volume>
            <issue>6</issue>
            <fpage>1586</fpage>
            <page-range>1586-91</page-range>
            <pub-id pub-id-type="pmid">17556697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jolliffe</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hooper</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Mathyssen</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rafiq</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>de Jongh</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Camargo</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Griffiths</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Janssens</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Martineau</surname>
                <given-names>AR</given-names>
              </name>
            </person-group>
            <article-title>Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials.</article-title>
            <source>Thorax</source>
            <year>2019</year>
            <month>Apr</month>
            <volume>74</volume>
            <issue>4</issue>
            <fpage>337</fpage>
            <page-range>337-345</page-range>
            <pub-id pub-id-type="pmid">30630893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31224.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gani</surname>
                <given-names>LU</given-names>
              </name>
              <name>
                <surname>How</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>PILL Series. Vitamin D deficiency.</article-title>
            <source>Singapore Med J</source>
            <year>2015</year>
            <month>Aug</month>
            <volume>56</volume>
            <issue>8</issue>
            <fpage>433</fpage>
            <page-range>433-6; quiz 437</page-range>
            <pub-id pub-id-type="pmid">26311908</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
